- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0283333

Canaan Lifescience Pharmaceuticals Limited
About Canaan Lifescience Pharmaceuticals Limited
Data last updated:
Canaan Lifescience Pharmaceuticals Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PLC325227. Its GSTIN is 07AAQCA1605G1ZV (Delhi).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Avon Forever Industries Limited. It is led by directors including Yogesh Rohidas Lanke and Nagnath Shktishiv Satpute.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Rz 201/17 Tughlakabad Extension, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹84.23 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹2.2 Lakh (net margin 2.6%) and EBITDA of ₹2.49 Lakh (EBITDA margin 3%).
Canaan Lifescience Pharmaceuticals Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0283333). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Canaan Lifescience Pharmaceuticals
Contact details
Canaan Lifescience Pharmaceuticals Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRz 201/17 Tughlakabad Extension, New Delhi, Delhi, India – 110019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Canaan Lifescience Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Canaan Lifescience Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Canaan Lifescience Pharmaceuticals Limited, buy the company report.
Financials of Canaan Lifescience Pharmaceuticals Limited
FY 2024 filings availableCanaan Lifescience Pharmaceuticals Limited reported revenue of ₹84.23 Lakh (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 20% in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.49 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Canaan Lifescience Pharmaceuticals Limited, buy the company report.
Board of directors of Canaan Lifescience Pharmaceuticals Limited
Canaan Lifescience Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yogesh Rohidas Lanke | Director | 26 Feb 2021 | 5 Years 8 Months | Current |
| Nagnath Shktishiv Satpute | Director | 26 Feb 2021 | 5 Years 8 Months | Current |
| Abhinav Maheshwari Sohanlal Also directs: Kosmonatura Wellness Private Limited | Director | 23 Oct 2017 | 9 Years 0 Months | Current |
Peer comparison
Canaan Lifescience Pharmaceuticals Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kruger Nutra Med Private Limited | ₹84.38 Lakh (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Sigma Solvents and Pharmaceuticals Limited | ₹84.35 Lakh (FY 2025) | -29.0% | Mehsana, Gujarat, India | |||
| Italia Pharmaceuticals Private Limited | ₹84.26 Lakh (FY 2024) | 102.0% | Indore, Madhya Pradesh, India | |||
| Canaan Lifescience Pharmaceuticals Limitedthis company | ₹84.23 Lakh (FY 2025) | ₹2.2 Lakh | 2.6% | 20.0% | New Delhi, Delhi, India | |
| Vivaceutical Private Limited | ₹83.85 Lakh (FY 2024) | 21.0% | Mohali, Punjab, India |
To see the full peer comparison of Canaan Lifescience Pharmaceuticals Limited, buy the company report.
Auditor
Canaan Lifescience Pharmaceuticals Limited is audited by SHARMA KUMAR & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHARMA KUMAR & ASSOCIATES | FY 2023 | 030842N |
Shareholding
The shareholding of Canaan Lifescience Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Canaan Lifescience Pharmaceuticals Limited, buy the company report.
Legal cases
No court or tribunal cases involving Canaan Lifescience Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Canaan Lifescience Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Canaan Lifescience Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAQCA1605G1ZV | Delhi | Active | 04 Jul 2018 |
To see the full GST registrations and return filing status of Canaan Lifescience Pharmaceuticals Limited, buy the company report.
Recent activity
Canaan Lifescience Pharmaceuticals Limited has 8 board changes on record since 2017: 3 appointments and 5 cessations. The latest: Prasad Bhosale Ashok ceased to be Director on 27 Feb 2021.
Frequently asked questions
Canaan Lifescience Pharmaceuticals is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 October 2017 (9+ years old) and is registered under CIN U74999DL2017PLC325227.
Canaan Lifescience Pharmaceuticals has 3 current directors:
- Yogesh Rohidas Lanke - Director
- Nagnath Shktishiv Satpute - Director
- Abhinav Maheshwari Sohanlal - Director
The latest financial statements of Canaan Lifescience Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Canaan Lifescience Pharmaceuticals is 07AAQCA1605G1ZV, registered in Delhi.
The CIN (Corporate Identification Number) of Canaan Lifescience Pharmaceuticals is U74999DL2017PLC325227. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Canaan Lifescience Pharmaceuticals was incorporated on 23 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Canaan Lifescience Pharmaceuticals by revenue are Kruger Nutra Med Private Limited, Sigma Solvents and Pharmaceuticals Limited, Italia Pharmaceuticals Private Limited, Vivaceutical Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prasad Bhosale Ashok ceased to be Director on 27 Feb 2021. Vishakha Prakash Desale ceased to be Director on 27 Feb 2021. Nagnath Shktishiv Satpute was appointed as Director on 26 Feb 2021. Canaan Lifescience Pharmaceuticals has 8 board changes on record in total.
Yes, Canaan Lifescience Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0283333).
The registered office of Canaan Lifescience Pharmaceuticals is at Rz 20117 Tughlakabad Extension, New Delhi, Delhi, India – 110019.
Canaan Lifescience Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

